Antigens, Cf (Including Cf Control), Influenza Virus A, B, C
FDA product code GNX · 18 cleared devices
Class 1
Microbiology
- Regulation
- 21 CFR 866.3330
- Review panel
- MI
- Implant
- No
- Life sustaining
- No
- Third party review
- No
- GMP exempt
- No
- Clearance span
- 1981-01-12 – 2013-12-05
GNX
2013-12-05
GNX
2013-08-22
SAS FLUALERT A & B, SAS INFLUENZA A TEST
View details →
GNX
2013-07-12
REMEL XPECT FLU A&B
View details →
GNX
2013-07-05
SOFIA INFLUENZA A+B FIA
View details →
GNX
2013-07-05
QUICK VUE INFLUENZA
View details →
GNX
2013-06-28
QUICKVUE INFLUENZA A+B
View details →
GNX
2012-11-05
OSOM INFLUENZA A&B TEST MODEL 190
View details →
GNX
1997-09-10
VIRAZYME INFLUENZA ID TEST FOR INFLUENZA TYPES A AND B VIRUSES
View details →
GNX
1992-12-29
BARTEL PRIMA SYSTEM INFLUENZA A ENZYME IMMUNOASSAY
View details →
GNX
1990-06-27
FITC MURINE MONOCLONAL ANTI-INFLUENZA TYPE B
View details →
GNX
1990-01-16
FITC MURINE MONOCLONAL ANTI-INFLUENZA TYPE A
View details →
GNX
1988-11-22
INFLUENZA A IFA TEST FOR DIRECT ANTIGEN DETECTION
View details →
GNX
1988-02-24
IMAGEN INFLUENZA VIRUS A AND B TESTMI
View details →
GNX
1987-06-26
ANTIBODY ASSAY FOR DETECTION OF INFLUENZA A
View details →
GNX
1987-06-26
ANTIBODY ASSAY FOR DETECTION OF INFLUENZA B
View details →
GNX
1985-09-26
IN FLUENZA B VIRUS
View details →
GNX
1985-09-26
INFLUENZA A2 VIRUS
View details →
GNX
1981-01-12
INFLUENZA A & B S-ANTIGEN & CONTROLS
View details →No matching devices.
Advertisement